- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07348081
Real World Evidence to Assess the Value of a Digital Care Coordination and Monitoring Program for Supporting Caregivers of Adults Discharged From the Emergency Department. (RW-HOMECARE)
The RW-HOMECARE study is a prospective, longitudinal, real-world pilot trial designed to assess the impact of proposing the Monka digital solution to non-professional caregivers of patients discharged from emergency or short-stay units. The primary objective is to measure changes in caregiver burden using the ZBI-12 scale at baseline, 30 days, and 90 days. Secondary objectives include evaluating caregivers' physical and mental quality of life (SF-12), patient frailty (Clinical Frailty Scale), and the incidence of adverse events such as emergency visits, unplanned hospitalizations, falls, institutionalization, and death within 90 days. The study also examines the usability, acceptability, and satisfaction with Monka digital solution through standardized questionnaires, the correlation between algorithm-generated vulnerability scores and established measures, and reasons for non-adoption.
Eligible dyads (patient and caregiver) are recruited at discharge from emergency or short-stay units. After informed consent, caregivers receive free access to Monka digital solution for 3 months, along with a user guide. Follow-up assessments are conducted by phone at Day 30 and Day 90 (±14 days). All interventions by the coordinating nurse are tracked and analyzed quantitatively and qualitatively.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Camilla GERLIER, Doctor
- Phone Number: 01·44·12·80·23
- Email: cgerlier@ghpsj.fr
Study Contact Backup
- Name: Célia MAMMA
- Phone Number: 01·44·12·32·54
- Email: cmamma@ghpsj.fr
Study Locations
-
-
-
Paris, France, 75014
- Recruiting
- Hopital Paris Saint-Joseph
-
Contact:
- Camille GERLIER
- Phone Number: 01·44·12·80·23
- Email: cgerlier@ghpsj.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
FOR THE PATIENT
- Person aged 18 or over, treated in the Emergency Department or Emergency Beds
- Affiliated with Social Security
- Having an adult non-professional relative helping them with one or more activities of daily living
- Having a medical decision to return home within the next 72 hours
- Who has given their free, informed, and express consent FOR THE CAREGIVER
- Individuals aged 18 or older
- Who are non-professional caregivers as defined in Article L. 113-1-3 of the Social Action and Families Code, living with or separately from the person being cared for (20)
- Providing assistance to the patient with one or more activities of daily living, i.e., shopping, medical appointments, coordination of care, administrative tasks, and moral support
- Access to a cell phone, computer, or tablet with an internet connection
- Having given their free, informed, and express consent
Exclusion Criteria:
FOR THE PATIENT
- Non-French speakers
- People living in a medical institution or scheduled for institutionalization within the next 3 months
- People receiving home hospitalization (HAD) or palliative care at home
- People under legal protection, deprived of their liberty, or under legal guardianship (tutelage or curatelle) FOR THE CAREGIVER
- Non-French speakers
- People with cognitive or psychiatric disorders that prevent them from understanding and using the MONKA solution
- People under legal protection, deprived of their liberty, or under legal guardianship (tutelage or curatelle)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Patient and caregiver dyad experiencing the MyMonka solution in real-life conditions
|
Testing of the MyMonka solution; Response to questionnaires during the follow-up period on quality of life and burden measurement
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in the score on the 12-item Zarit Burden Interview questionnaire (ZBI-12, Appendix 1), measured on days 0, 30, and 90, among family caregivers participating in the study.
Time Frame: Days 0, 30 and 90
|
Days 0, 30 and 90
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in the physical and mental quality of life of caregivers, expressed as the difference between SF-12 questionnaire scores at baseline, on day 30, and on day 90.
Time Frame: Days 30 and 90
|
Days 30 and 90
|
|
Change in patient frailty expressed as the difference between the Clinical Frailty Scale score obtained at inclusion and on day 90.
Time Frame: Days 0 and 90
|
Days 0 and 90
|
|
Percentage of people affected by the following adverse events within three months of returning home: new emergency room visits, unscheduled hospitalizations and their duration, falls, home hospitalizations, institutionalization, and death.
Time Frame: Days 90
|
Days 90
|
|
Evaluation of the use, acceptability, usability, and impact of the Monka digital solution for caregivers through intervention tracking, algorithm-based vulnerability assessment, and standardized questionnaires over a 90-day period.
Time Frame: Days 0 and 90
|
Days 0 and 90
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 782_RW-HOMECARE
- ID RCB : 2025-A02182-47 (Other Identifier: ANSM)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Frailty Syndrome
-
University of PennsylvaniaCompleted
-
Hospital Universitario GetafeKarolinska Institutet; Medical University of Lodz; Universidad Politecnica de... and other collaboratorsUnknownFrail Elderly Syndrome | Frailty | Frailty SyndromePoland, Spain, Sweden
-
University of AlbertaAlberta Health services; Glenrose FoundationCompletedHealthy | Frail Elderly Syndrome | Frailty | Healthy Aging | Frailty Syndrome | Aging Problems | Aging Disorder | Pre-FrailtyCanada
-
Meridigen Biotech Co., Ltd.Recruiting
-
Wroclaw Medical UniversityCompleted
-
Ageless Regenerative InstituteInstituto de Medicina RegenerativaWithdrawn
-
University of NottinghamMedical Research Council; National Institute for Health Research, United KingdomRecruitingFrail Elderly Syndrome | Frailty | Frailty SyndromeUnited Kingdom
-
Haukeland University HospitalRecruitingFrail Elderly Syndrome | Frailty | Aging | Frailty SyndromeNorway
-
Brigham and Women's HospitalCompletedFrail Elderly Syndrome | Frailty | Aging | Frailty SyndromeUnited States
-
Geriatric Education and Research InstituteSingapore General Hospital; Changi General Hospital; Sengkang General Hospital; Alexandra Hospital and other collaboratorsCompletedFrail Elderly Syndrome | Frailty | Frailty SyndromeSingapore
Clinical Trials on Caregivers supporting vulnerable patients and using the MyMonka solution.
-
Laval UniversityCISSS de Chaudière-Appalaches; Institut national d'excellence en santé et service...RecruitingDementia | Alzheimer Disease | Neurocognitive DeclineCanada
-
Can Tho University of Medicine and PharmacyCompletedAlveolar Bone Loss | Angle Class IVietnam
-
Gaziosmanpasa Research and Education HospitalCompleted
-
Ankara UniversityRecruiting
-
Robert Wood Johnson FoundationCompletedDiabetes MellitusUnited States
-
Damascus UniversityCompletedDental Caries | Primary Teeth | PulpotomySyrian Arab Republic
-
Damascus UniversityCompletedAnesthesia, Local | Dental Anxiety | Behavior, ChildSyrian Arab Republic
-
Cai gaojun, MDRecruitingCoronary Artery DiseaseChina
-
R&D CardiologieRecruitingAtrial FibrillationNetherlands